Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way
Personalized Medicine is one of the most innovative areas of the future of health research. It has a high potential for patients, citizens and the economy. However, it cannot be developed due to fragmented activities, insufficient communication and lack of generic solutions. The necessity of implementing activities in this field represents a major challenge in Europe.
The Coordination & Support Action (CSA) PerMed was initiated to step up coordination efforts between European key stakeholders, to allow synergies and avoid duplication or competition, to ensure maximum transparency and openness preparing Europe for leading the global way. The project aims to provide a dialogue platform for all relevant actors involved in Personalized Medicine and to lower barriers for the implementation of it in research, industry and healthcare.
The ultimate goals of the CSA PerMed are:
- To complement existing activities by identifying and promoting research topics
- To develop strategic research and innovation agendas in Europe and beyond
- To bring forward the implementation of Personalized Medicine for the benefit of society
The project was launched in 2013 and is planned to be finalised in 2015.